country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-182435

Copy Link Print Information

CLE-030

CLE-030 is a KCNQ2 agonist with non-gating-dependent current-modulating activity. CLE-030 modulates neuronal network activity. CLE-030 can be used in studies related to pain, epilepsy and benign familial neonatal convulsions.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 2803111-66-0
Formel: C₂₀H₂₀Br₂N₄OS₂
Molecular Weight:556.34

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

CLE-030 Chemical Structure

CAS. Nr.: 2803111-66-0

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

In Vitro

CLE-030 (Compound 34) (10 μM; for at least 3 min) increases channel currents in CHO-K1 cells transfected with human KCNQ2^[1].
CLE-030 (0.1-10 μM) potently activates wild-type human KCNQ2 channels expressed in CHO cells, with an EC₅₀ of 3.9 μM. It enhances channel currents without altering voltage sensitivity or gating kinetics^[2].
CLE-030 (0.1-10 μM) shows significantly reduced activation potency toward W236A, L299A, and V302A mutant KCNQ2 channels expressed in CHO cells^[2].
CLE-030 (0.1-10 μM) selectively activates human KCNQ2, KCNQ4 and KCNQ5 channels expressed in CHO cells, and exhibits no significant activity against KCNQ1, KCNQ3^A315T, BK_Ca, Kv1.2, Kir4.1 or TREK-1 channels^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS. Nr. 2803111-66-0
Molecular Weight 556.34
Formel C₂₀H₂₀Br₂N₄OS₂
SMILES

O=C(CSC1=NN=C(CSCC2=CC=C(C)C=C2)N1C)NC3=CC=C(C=C3Br)Br
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Yang Huaiyu, et al. Triazole derivative and preparation method and application thereof. CN116763781A. 2023-09-19.

[2]. Liu S, et al. General Pharmacological Activation Mechanism of K⁺ Channels Bypassing Channel Gates. J Med Chem. 2022;65(15):10285-10299. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen